Nutritional considerations in renal transplant patients

Blood Purification

Volumn 20, Issue 2, 2002, Pages 139-144

  Van Den Ham, Eugénie C H ^a   Kooman, Jeroen P ^a   Van Hooff, Johannes P ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Dietary intervention; Immunosuppression; Metabolism; Nutritional state; Physical activity; Renal transplantation

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; STEROID;

APPETITE; BODY COMPOSITION; BODY FAT; DIET; DOSE CALCULATION; DRUG EFFECT; EXERCISE; GRAFT REJECTION; HUMAN; HYPERLIPIDEMIA; IMMOBILIZATION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LIPID PEROXIDATION; METABOLISM; NUTRITION; NUTRITIONAL REQUIREMENT; PHYSICAL ACTIVITY; PHYSIOLOGY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; UREMIA; WEIGHT GAIN; NUTRITIONAL STATUS;

BODY COMPOSITION; DIET; EXERCISE; HUMAN; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; NUTRITIONAL STATUS; HUMANS;

EID: 0036017958     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000046999     Document Type: Review

References (57)

1. Nutritional status of diabetic and nondiabetic patients after renal transplantation
2. Body composition in renal transplant patients: Bioimpedance analysis compared to isotope dilution, dual X-ray absorptiometry, and anthropometry
3. Assessment of the nutritional state of dialysis patients
4. Middle-sized molecule fractions isolated from uremic ultrafiltrate and normal urine inhibit ingestive behavior in the rat
5. Leptin - A new hormone of definite interest for the nephrologist
6. Nutritional aspects in hemodialysis
7. Changes in patients' eating behavior: In the uremic state, on continuous ambulatory peritoneal dialysis treatment, and after transplantation
8. Hyperleptinaemia of end-stage renal disease is corrected by renal transplantation
9. Plasma immunoreactive leptin and neuropeptide Y levels in kidney transplant patients
10. Nutritional status, muscle composition and plasma and muscle free amino acids in renal transplant patients
11. Relationship between nutritional status and the glomerular filtration rate: Results from the MDRD study
12. Factors influencing weight gain after renal transplantation
13. The hypomagnesaemic action of FK506: Urinary excretion of magnesium and calcium and the role of parathyroid hormone
14. Skeletal muscle magnesium content during cyclosporin and azathioprine treatment in renal transplant recipients
15. Metabolic aspects of phosphate replacement therapy for hypophosphataemia after renal transplantation: Impact on muscular phosphate content, mineral metabolism, and acid/base homeostasis
16. Effects of oral magnesium supplementation on acute experimental cyclosporin nephrotoxicity
17. Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506
18. Impaired phosphate handling of renal allografts is aggravated under rapamycin-based immunosuppression
19. 31P nuclear magnetic resonance spectroscopy
20. Cyclosporine inhibits phosphate transport and stimulates alkaline phosphate activity in renal BBMV
21. Dissociation of absortion of calcium and phosphate after successful renal transplantation
22. Muscleskeletal complications after renal transplantation: Pathogenesis and treatment
23. Hypophosphataemia: Pathophysiological and practical aspects of its therapy
24. The effect of dietary intervention on weight gains after renal transplantation
25. Body composition and fuel metabolism after kidney grafting
26. Posttransplantation weight gain is predominantly due to an increase in body fat mass
27. Effects of renal transplantation on body composition
28. Differential effects of prednisone and growth hormone on fuel metabolism and insulin antagonism in humans
29. Nutritional requirements of renal transplant patients
30. The influence of glucocorticoid dose on protein catabolism after renal transplantation
31. Altered body composition and fuel metabolism in stable kidney transplant patients on immuno-suppressive monotherapy with cyclosporine A
32. Nutritional status of diabetic and nondiabetic patients after renal transplantation
33. Evidence that prednisone-induced myopathy is reversed by physical training
34. Relation between steroid dose, body composition and physical activity in renal transplant patients
35. The impact of steroid withdrawal on the development of lipid abnormalities and obesity in heart transplant recipients
36. Triple-drug immunosuppression with steroid discontinuation by six months after heart transplantation
37. Amelioration of weight gain after heart transplantation by corticosteroid-free maintenance immunosuppression
38. Skeletal muscle limits the exercise tolerance of renal transplant recipients: Effects of a graded exercise training program
39. Exercise tolerance changes following renal transplantation
40. Graded exercise testing and training after renal transplantation: A preliminary study
41. Patterns of early weight change after renal transplantation
42. Post-transplant hyperlipidemia: Mechanisms and management
43. Cardiovascular disease after renal transplantation
44. Hyperlipidemia and transplantation: Etiologic factors and therapy
45. Excess abdominal adiposity remains correlated with altered lipid concentrations in healthy older women
46. Fat distribution and health in obesity
47. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 Year follow up of participants in the study of men born in 1913
48. Patient profile and effect of dietary therapy on post-transplant hyperlipidemia
49. Is dietary intervention effective in post-transplant hyperlipidaemia?
50. Effect of diet and fluvastatin treatment on the serum lipid profile of kidney transplant, diabetic recipients: A 1-year follow up
51. Can low-fat/cholesterol nutrition counseling improve food intake habits and hyperlipidemia of renal transplant patients?
52. Nutrition in renal transplantation
53. Renal transplant diet recommendations: Results of a survey of renal dietitians in the United States
54. Dietary protein intake and nutritional status in patients with renal transplant
55. Effects of dietary protein in patients with chronic renal transplant rejection
56. Impact and management of hyperlipidemia posttransplantation
57. Hyperlipidemia in solid organ transplantation